LU72306A1 - - Google Patents
Info
- Publication number
- LU72306A1 LU72306A1 LU72306A LU72306A LU72306A1 LU 72306 A1 LU72306 A1 LU 72306A1 LU 72306 A LU72306 A LU 72306A LU 72306 A LU72306 A LU 72306A LU 72306 A1 LU72306 A1 LU 72306A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
- C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
- C07D331/04—Four-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46169974A | 1974-04-17 | 1974-04-17 | |
| US05/555,307 US4009847A (en) | 1974-04-17 | 1975-03-11 | 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU72306A1 true LU72306A1 (en:Method) | 1976-03-17 |
Family
ID=27040095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU72306A LU72306A1 (en:Method) | 1974-04-17 | 1975-04-17 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4009847A (en:Method) |
| JP (1) | JPS50148349A (en:Method) |
| AR (1) | AR208545A1 (en:Method) |
| CA (1) | CA1047042A (en:Method) |
| CH (1) | CH611292A5 (en:Method) |
| DD (1) | DD117223A5 (en:Method) |
| DE (1) | DE2516554A1 (en:Method) |
| DK (1) | DK164175A (en:Method) |
| ES (1) | ES436648A1 (en:Method) |
| FI (1) | FI751128A7 (en:Method) |
| FR (1) | FR2267773B1 (en:Method) |
| GB (1) | GB1461209A (en:Method) |
| HU (1) | HU173052B (en:Method) |
| IE (1) | IE41143B1 (en:Method) |
| IL (1) | IL47095A (en:Method) |
| LU (1) | LU72306A1 (en:Method) |
| NL (1) | NL7504570A (en:Method) |
| NO (1) | NO144071C (en:Method) |
| PH (1) | PH11722A (en:Method) |
| SE (1) | SE417965B (en:Method) |
| YU (1) | YU96075A (en:Method) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4156738A (en) * | 1977-10-07 | 1979-05-29 | E. I. Du Pont De Nemours And Company | Ureidonitriles useful as antihypertensives |
| US6187799B1 (en) * | 1997-05-23 | 2001-02-13 | Onyx Pharmaceuticals | Inhibition of raf kinase activity using aryl ureas |
| US6344476B1 (en) * | 1997-05-23 | 2002-02-05 | Bayer Corporation | Inhibition of p38 kinase activity by aryl ureas |
| US7517880B2 (en) | 1997-12-22 | 2009-04-14 | Bayer Pharmaceuticals Corporation | Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| US20080300281A1 (en) * | 1997-12-22 | 2008-12-04 | Jacques Dumas | Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas |
| US7329670B1 (en) | 1997-12-22 | 2008-02-12 | Bayer Pharmaceuticals Corporation | Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas |
| US20080269265A1 (en) * | 1998-12-22 | 2008-10-30 | Scott Miller | Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas |
| EP1140840B1 (en) | 1999-01-13 | 2006-03-22 | Bayer Pharmaceuticals Corp. | -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US8124630B2 (en) * | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| HK1042251B (en) * | 1999-01-13 | 2012-07-20 | Bayer Healthcare Llc | Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors |
| ME00275B (me) | 1999-01-13 | 2011-02-10 | Bayer Corp | ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE |
| US7928239B2 (en) | 1999-01-13 | 2011-04-19 | Bayer Healthcare Llc | Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas |
| US7235576B1 (en) | 2001-01-12 | 2007-06-26 | Bayer Pharmaceuticals Corporation | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US7371763B2 (en) * | 2001-04-20 | 2008-05-13 | Bayer Pharmaceuticals Corporation | Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas |
| ES2275931T5 (es) * | 2001-12-03 | 2018-10-23 | Bayer Healthcare Llc | Compuestos de aril-urea en combinación con otros agentes citostáticos o citotóxicos para tratamiento de cánceres humanos |
| US20080108672A1 (en) * | 2002-01-11 | 2008-05-08 | Bernd Riedl | Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors |
| CA2475703C (en) * | 2002-02-11 | 2016-12-20 | Bayer Pharmaceuticals Corporation | Aryl ureas with angiogenesis inhibiting activity |
| US20030216396A1 (en) | 2002-02-11 | 2003-11-20 | Bayer Corporation | Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors |
| DK1580188T3 (da) * | 2002-02-11 | 2012-02-06 | Bayer Healthcare Llc | Forbindelser af arylurea som kinaseinhibitorer |
| WO2003068223A1 (en) * | 2002-02-11 | 2003-08-21 | Bayer Corporation | Aryl ureas with raf kinase and angiogenesis inhibiting activity |
| UY28213A1 (es) | 2003-02-28 | 2004-09-30 | Bayer Pharmaceuticals Corp | Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos. |
| ATE366108T1 (de) * | 2003-05-20 | 2007-07-15 | Bayer Pharmaceuticals Corp | Diaryl-harnstoffe für durch pdgfr vermittelte krankheiten |
| PL1663978T3 (pl) * | 2003-07-23 | 2008-04-30 | Bayer Healthcare Llc | Fluoropodstawiony omega-karboksyarylodifenylomocznik do leczenia i profilaktyki chorób i stanów |
| CA2564325A1 (en) * | 2004-04-30 | 2005-11-24 | Bayer Pharmaceuticals Corporation | Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH452475A (de) * | 1965-05-20 | 1968-05-31 | Bayer Ag | Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen |
-
1975
- 1975-03-11 US US05/555,307 patent/US4009847A/en not_active Expired - Lifetime
- 1975-03-26 SE SE7503523A patent/SE417965B/xx unknown
- 1975-04-15 CA CA224,634A patent/CA1047042A/en not_active Expired
- 1975-04-15 IL IL47095A patent/IL47095A/xx unknown
- 1975-04-16 FI FI751128A patent/FI751128A7/fi not_active Application Discontinuation
- 1975-04-16 YU YU00960/75A patent/YU96075A/xx unknown
- 1975-04-16 ES ES436648A patent/ES436648A1/es not_active Expired
- 1975-04-16 AR AR258396A patent/AR208545A1/es active
- 1975-04-16 DE DE19752516554 patent/DE2516554A1/de not_active Withdrawn
- 1975-04-16 DK DK164175A patent/DK164175A/da not_active IP Right Cessation
- 1975-04-16 DD DD185482A patent/DD117223A5/xx unknown
- 1975-04-16 HU HU75DU237A patent/HU173052B/hu unknown
- 1975-04-16 PH PH17061A patent/PH11722A/en unknown
- 1975-04-16 GB GB1567175A patent/GB1461209A/en not_active Expired
- 1975-04-16 NO NO751351A patent/NO144071C/no unknown
- 1975-04-16 FR FR7511796A patent/FR2267773B1/fr not_active Expired
- 1975-04-17 JP JP50045924A patent/JPS50148349A/ja active Pending
- 1975-04-17 LU LU72306A patent/LU72306A1/xx unknown
- 1975-04-17 IE IE865/75A patent/IE41143B1/xx unknown
- 1975-04-17 CH CH494875A patent/CH611292A5/xx not_active IP Right Cessation
- 1975-04-17 NL NL7504570A patent/NL7504570A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GB1461209A (en) | 1977-01-13 |
| JPS50148349A (en:Method) | 1975-11-27 |
| NO144071C (no) | 1981-06-17 |
| IL47095A (en) | 1978-03-10 |
| CH611292A5 (en:Method) | 1979-05-31 |
| ES436648A1 (es) | 1977-08-01 |
| FR2267773B1 (en:Method) | 1978-08-18 |
| DD117223A5 (en:Method) | 1976-01-05 |
| SE417965B (sv) | 1981-04-27 |
| US4009847A (en) | 1977-03-01 |
| NO144071B (no) | 1981-03-09 |
| DE2516554A1 (de) | 1975-10-30 |
| DK164175A (da) | 1975-10-18 |
| AR208545A1 (es) | 1977-02-15 |
| HU173052B (hu) | 1979-02-28 |
| IE41143B1 (en) | 1979-10-24 |
| CA1047042A (en) | 1979-01-23 |
| YU96075A (en) | 1983-04-27 |
| SE7503523L (sv) | 1975-10-20 |
| PH11722A (en) | 1978-05-30 |
| NL7504570A (nl) | 1975-10-21 |
| NO751351L (en:Method) | 1975-10-20 |
| AU8013575A (en) | 1976-10-21 |
| IL47095A0 (en) | 1975-06-25 |
| FR2267773A1 (en:Method) | 1975-11-14 |
| FI751128A7 (en:Method) | 1975-10-18 |
| IE41143L (en) | 1975-10-17 |